Founding Partner
A Class I recall involving the Philips Lumify Diagnostic Ultrasound System has raised serious patient safety concerns following reports of four deaths and eight serious injuries associated with device problems. On October 19, 2026, the U.S. Food and Drug Administration (FDA) formally classified the recall as Class I, its most serious category. The reported malfunctions involve software recognition failures and unstable USB connections that can interrupt ultrasound examinations when healthcare providers need immediate diagnostic information.
The Lumify system is designed to provide portable ultrasound imaging through compatible smartphones and tablets. Its portability makes it particularly useful in emergency departments, ambulances, medical aircraft, and remote healthcare environments where conventional ultrasound equipment may not be readily available. However, the reported defects can interfere with examinations and potentially delay important medical decisions.
According to information provided about the FDA recall, Philips reported eight serious injuries and four deaths associated with the device problems as of September 29, 2026. These reports warrant investigation, although they do not independently establish that the malfunctions caused each injury or death.
Patients who suffered preventable injuries, as well as families who lost loved ones following examinations involving potentially defective Philips Lumify equipment, may have grounds to investigate a medical device product liability lawsuit.
A Class I recall means there is a reasonable probability that continued use of a medical device in the circumstances identified could cause serious adverse health consequences or death. The designation does not mean every affected device has malfunctioned, but it signals a potentially significant safety hazard.
Philips initiated its corrective action on September 24, 2026. The FDA issued an early alert on October 9 and updated its public communication on October 19 to confirm the Class I classification. The FDA recall database identifies recall number Z-0152-2027 and lists 13,206 devices in commerce worldwide. Importantly, this is a correction involving updated operating instructions, not an instruction to remove every device from service.
One reported defect involves the Lumify application failing to recognize an ultrasound transducer that was previously registered. When this occurs, the system may unexpectedly require another registration before scanning can resume. Because registration requires internet access, clinicians working without a reliable Wi-Fi or cellular connection may be unable to complete the examination.
This problem is particularly concerning during emergency transportation. An ambulance traveling through an area with limited cellular coverage or a medical helicopter transporting a critically ill patient may not have dependable connectivity. If the ultrasound system suddenly becomes unavailable, healthcare professionals may lose access to diagnostic information needed to determine the patient’s condition or select appropriate treatment.
The second problem involves unstable USB connections between the ultrasound transducer and its connected smartphone or tablet. A disrupted connection can interrupt continuous imaging, potentially forcing medical personnel to troubleshoot equipment when immediate patient assessment is necessary.
The FDA specifically recognizes that these malfunctions can delay diagnosis and treatment. Philips has been developing a software correction and investigating the connection issue.
Portable ultrasound equipment helps clinicians assess potentially life-threatening conditions without waiting for conventional imaging equipment. Depending on the patient’s symptoms, an examination may help identify internal bleeding, cardiac abnormalities, fluid accumulation, or other medical emergencies requiring immediate intervention.
For example, a patient suffering traumatic injuries may need rapid assessment for internal bleeding. If ultrasound imaging becomes unavailable, clinicians may need alternative diagnostic methods, potentially delaying treatment. Similarly, interruptions during cardiac assessment may complicate decisions about emergency interventions.
Not every interruption results in injury, and clinicians may have other diagnostic options available. Nevertheless, when a patient is critically ill, even a relatively short delay may have serious consequences. Determining whether a malfunction contributed to an injury requires reviewing the patient’s medical condition, available alternative equipment, and the actual treatment timeline.
Patients who suffered serious injuries following an examination interrupted by a recalled Lumify system may have grounds to investigate a product liability claim. Potential cases could involve delayed diagnoses, deterioration of an existing medical emergency, additional medical procedures, permanent disabilities, or death.
A successful lawsuit generally requires evidence connecting an actionable defect or other legally recognized wrongdoing to the patient’s injuries. The fact that a patient was examined using a recalled device does not automatically establish liability.
Depending on the circumstances and applicable state law, claims may involve defective design, inadequate warnings, negligence, or other product liability theories. Medical malpractice claims may also warrant investigation if healthcare providers failed to respond appropriately to a known malfunction. Federal medical device regulations and preemption defenses may affect which claims are legally available.
Patients who establish liability may be entitled to compensation for medical expenses, hospitalization, rehabilitation, additional treatment, and future healthcare needs. Claims may also include lost income, diminished earning capacity, physical pain, emotional suffering, and permanent impairment.
When a malfunction contributes to a fatal outcome, eligible surviving family members or estate representatives may pursue wrongful death or survival claims. Recoverable damages depend on state law and may include funeral expenses, lost financial support, and other legally recognized losses.
The value of any claim depends on the severity of the injury, the strength of the evidence, applicable legal rules, and the extent to which the alleged defect contributed to the outcome.
Medical records are essential because they establish the patient’s condition, the timing of diagnostic examinations, and the treatment provided. Emergency medical services reports, hospital documentation, imaging records, and transportation records may reveal whether an ultrasound examination was interrupted or delayed.
Device identification information, software versions, maintenance records, connection logs, and incident reports may also help determine whether the equipment experienced a recalled malfunction. Witness statements from treating healthcare professionals could provide additional information about what happened.
Because electronic records may be overwritten and equipment may be repaired or updated, preserving relevant evidence promptly can be particularly important. An attorney can investigate appropriate preservation requests and determine whether the available documentation supports a claim.
You may have grounds to investigate a lawsuit if a device malfunction caused or contributed to a harmful delay in diagnosis or treatment. A claim generally requires proof of an actionable defect, causation, and compensable injuries. Medical records and equipment information can help determine whether those requirements are satisfied.
Eligible family members or estate representatives may pursue wrongful death claims when evidence establishes that a legally actionable malfunction contributed to a patient’s death. Eligibility, filing procedures, and available compensation depend on the applicable state’s wrongful death laws. An investigation must distinguish a reported device problem from the medical cause of death.
Patients can request medical records, emergency transportation documentation, and diagnostic imaging reports to identify equipment used during treatment. Some records may identify the device manufacturer or model, while others may require further investigation. An attorney may help obtain additional information when there is a reasonable basis to suspect equipment failure.
No. The classification establishes that the FDA identified a serious potential safety risk, but it does not independently prove liability in an individual case. Plaintiffs generally must establish the relevant legal elements, including causation and damages, while addressing any defenses available under applicable law.
Filing deadlines vary by state and the legal claims involved. Some deadlines begin when an injury occurs, while others may depend on when an injury or its possible cause was reasonably discovered. Wrongful death claims may follow different rules. Prompt legal review can help protect potentially available rights.
Potential compensation may include past and future medical expenses, lost wages, reduced earning capacity, physical suffering, and other documented losses. Fatal injury claims may involve funeral expenses and losses recognized under applicable wrongful death statutes. Compensation is not guaranteed, and recoverable damages depend on the evidence and governing law.
Obtain appropriate medical care, request relevant treatment records, and document the circumstances surrounding the examination. Preserve communications and any information identifying the ultrasound equipment. Patients can also report suspected medical device problems through the FDA’s MedWatch program. Consulting an attorney promptly may help preserve evidence before it becomes unavailable.
Patients depend on medical equipment to function properly, particularly during emergencies when immediate diagnosis and treatment can mean the difference between recovery and permanent injury. When a potentially defective medical device interrupts critical care, injured patients and their families deserve answers about what happened and whether the harm could have been prevented.
Parker Waichman LLP is a national personal injury law firm representing individuals and families harmed by allegedly defective medical devices and other dangerous products. The firm can investigate potential Philips Lumify ultrasound injury claims, evaluate relevant medical evidence, and determine whether legal action may be appropriate.
If you or a loved one suffered serious injuries or a fatal outcome potentially associated with a Philips Lumify ultrasound malfunction, contact Parker Waichman LLP for a free consultation.
Call 1-800-YOUR-LAWYER (1-800-968-7529) to discuss your potential Philips Lumify ultrasound recall lawsuit. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
We handle mass torts cases nationwide. Please contact our office to learn more.